Archive for the ‘Healthcare News’ Category:

Exercise: How Even a Little May Help Older Hearts

Cardiovascular disease event risk in older adults with less mobility may be reduced with light physical activity. Older adults with reduced mobility may not move around a lot, but a little activity may go a long way in maintaining their heart health. Source: Daily Rx Read More

Poor response to cholesterol drugs may indicate blocked arteries

Patients whose bad cholesterol levels don't respond to cholesterol-lowering statin drugs may have more artery blockages than those whose cholesterol levels drop with treatment. Source: Medical News Today Read More

Dr. Vijay Ramanath performed the very first drug coated balloon angioplasty using the In.PACT Admiral device in Dallas Fort Worth.

Dr. Vijay Ramanath performed the very first drug coated balloon angioplasty using the In.PACT Admiral device in Dallas Fort Worth. We have an exciting announcement! On Feb 4, 2015, our very own Dr. Vijay Ramanath of HeartPlace Plano West, performed the very first drug coated balloon angioplasty using the In.PACT Admiral device in Dallas Fort Worth at THR Plano. We are excited to be the first practice in the Dallas Fort Worth area to utilize this new cardiac procedure to treat Vascular Disease in Texas. Drug coated balloons are a brand new technology that will revolutionize how we treat arterial blockages in the upper legs. Current therapies including balloon angioplasty and stenting provide suboptimal long-term outcomes. Drug coated balloons provide delivery of a medication to the arterial wall that helps prevents re-narrowing of the previously treated blockage, without leaving any metal scaffolding in the artery which may limit future therapeutic options. Current data shows superiority of drug coated balloon angioplasty compared to conventional balloon angioplasty with regards to success in keeping the artery open post-treatment. Bellow are before and after pictures of this brand new procedure. You can clearly see the amazing results. "Before "After To read more about this exciting new procedure, please read the official press release from the FDA webpage here. At HeartPlace, we offer cardiovascular treatment and services led by prominent physicians recognized for their contributions to advancing patient care. HeartPlace provides compassionate and cutting-edge preventive, diagnostic, and therapeutic services. We are the oldest and largest cardiovascular group in North Texas. Our commitment to quality includes board certification of our physicians, accreditation of our imaging centers, and the latest technologies. HeartPlace prides itself on being able to deliver quality care whether it is a simple problem such as blood pressure or complicated procedures such as robotic surgery or cardiac transplantation. HeartPlace is the past, present, and future of cardiology in North Texas.

Memory complaints link to stroke risk for the highly educated

Forgetting why you have gone into a room or misplacing your keys is frustrating, but new research suggests that these lapses in memory could signal more than just absent-mindedness. A new study has found that highly educated people with memory complaints could have an increased risk for stroke Source: Medical News Today Read More

Comparison of blood clot treatments illuminate recurrence risk in high-risk groups

Studies presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition compare new and standard-of-care treatments for blood clots and further illuminate clot risks in vulnerable populations, such as cancer patients. Source: Medical News Today Read More

Medtronic drug-coated balloon for peripheral artery disease tops standard balloon angioplasty in landmark study

The results of a landmark study published this month in Circulation, indicate that a novel medical device from Medtronic, Inc. called the IN.PACT Admiral drug-coated balloon (DCB) significantly outperformed standard balloon angioplasty in the treatment of symptomatic peripheral artery disease in the upper leg - specifically, the superficial femoral and proximal popliteal arteries. Source: Medical News Today Read More

NuVascular Technologies and Worcester Polytechnic Institute commercializing stem cell treatment to repair heart damage

NuVascular Technologies, Inc. has recently obtained exclusive licensing rights to commercialize a breakthrough medical device that will provide a minimally invasive treatment for heart disease, the No. 1 cause of death in the United States accounting for one in every four deaths. Source: Medical News Today Read More

Breakthrough: Statin treatment reduces risk of cardiovascular disease in women

A large international study has shown conclusively that statin treatment reduces the risk of cardiovascular disease in women. The research confirms that statins are beneficial not only to women who have already had a cardiovascular event such as a heart attack or stroke, but also in those who - whilst they have not yet developed cardiovascular disease -- are at an increased risk of such diseases. Source: Science Daily Read More

Significant link between daily physical activity, vascular health

As millions of Americans resolve to live healthier lives in 2015, research shows just how important diligent daily physical activity is. The researchers found that reducing daily physical activity for even a few days leads to decreases in the function of the inner lining of blood vessels in the legs of young, healthy subjects causing vascular dysfunction that can have prolonged effects. Source: Science Daily Read More

Prostate cancer medications linked with increased risk of heart-related deaths in men with cardiovascular problems

A new study has found that certain prostate cancer medications are linked with an increased risk of dying from heart-related causes in men with congestive heart failure or prior heart attacks. Source: Science Daily Read More
First | Previous | Pages 5 6 7 8 9 [10] 11 12 of 12 | Next | Last